Invitrogen Corp (NASDAQ:IVGN.DL)
CAPS Rating:
A developer, manufacturer and marketer of research tools in reagent, kit and high-throughput applications forms to customers engaged in life sciences research, drug discovery, diagnostics and the commercial manufacture of biological products.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
No players have picked IVGN.DL yet. Tell us why you think IVGN.DL will outperform or underperform the market.
RSS Headlines
Fool UK
